Rapid and durable recovery of visual function in a patient with von hippel-lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416. [electronic resource]
- Ophthalmology Sep 2002
- 1745-51 p. digital
Publication Type: Case Reports; Journal Article
0161-6420
10.1016/s0161-6420(02)01159-4 doi
Angiogenesis Inhibitors--therapeutic use Contrast Sensitivity Female Fluorescein Angiography Hemangioblastoma--drug therapy Humans Indoles--therapeutic use Magnetic Resonance Imaging Middle Aged Optic Disk--drug effects Optic Nerve Neoplasms--drug therapy Pyrroles--therapeutic use Receptor Protein-Tyrosine Kinases--antagonists & inhibitors Receptors, Growth Factor--antagonists & inhibitors Receptors, Vascular Endothelial Growth Factor Recovery of Function Visual Acuity--physiology Visual Fields von Hippel-Lindau Disease--drug therapy